Free Republic 2nd Qtr 2025 Fundraising Target: $81,000 Receipts & Pledges to-date: $62,537
77%  
Woo hoo!! And we're now over 77%!! Thank you all very much!! God bless.

Keyword: evusheld

Brevity: Headers | « Text »
  • CDC Issues New COVID-19 Guidance After FDA Makes Change

    01/29/2023 1:02:25 PM PST · by lightman · 9 replies
    epoch times ^ | 29 January A.D. 2023 | Jack Phillips
    The Centers for Disease Control and Prevention (CDC) issued new guidance to people with weak immune systems, saying they should take extra precautions after a key COVID-19 antibody treatment’s emergency use authorization was pulled by another federal agency. The guidance again calls for immunocompromised individuals to wear masks and engage in social distancing, the CDC’s revised guidance says, despite CDC-cited studies and data suggesting that masks provide little effectiveness in blocking the transmission of COVID-19. Some former federal officials have said that the six-foot social distancing rule adopted around the United States in early 2020 was arbitrary. Last week, the...
  • DeSantis touts monoclonal antibody drug, calls other state’s COVID policies ‘insanity’

    12/19/2021 7:14:06 AM PST · by conservative98 · 14 replies
    NY Post ^ | December 19, 2021 | Sam Raskin
    Gov. Ron DeSantis declared he is “committed” to ensuring new COVID-19 monoclonal antibody treatment will be administered to vulnerable Floridians. The long-acting AstraZeneca therapy known as Evusheld will be available to moderately to severely immunocompromised people like cancer patients, he said. “We are committed to doing the monoclonal,” DeSantis said Friday during a news conference, according to ABC affiliate Local 10. “We will make sure the dose sites are available.” The Sunshine State has just 3,100 doses of the antibody drug, favored by opponents COVID-19 vaccines, which will be given to the state’s hospitals and clinics that are performing such...
  • New COVID-19 antibody drug OK’d to protect most vulnerable

    12/11/2021 2:10:07 AM PST · by blueplum · 10 replies
    AP ^ | 08 December 2021 | MATTHEW PERRONE
    WASHINGTON (AP) — Federal health officials on Wednesday authorized a new COVID-19 antibody drug for people with serious health problems or allergies who can’t get adequate protection from vaccination. Antibody drugs have been a standard treatment for treating COVID-19 infections for over a year. But the AstraZeneca antibody drug cleared by the Food and Drug Administration is different. It’s the first intended for long-term prevention against COVID-19 infection, rather than a short-term treatment. People who could benefit from the antibody drug include cancer patients, organ transplant recipients and people taking immune-suppressing drugs....the required two antibody injections may be effective at...